VectorY

VectorY Therapeutics

Amsterdam, Netherlands · Founded 2020 · $175.6M raised

Headquarters
Amsterdam
Employees
51–200
Founded
2020
Business Model
B2B
Total Funding
$175.6M
Last Round
$138.0M Series ANov 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

VectorY Therapeutics is an Amsterdam-based fully integrated gene therapy company developing vectorized antibody treatments for neurodegenerative diseases including ALS. Founded in August 2020, VectorY combines AAV-based gene therapy with antibody science and operates proprietary R&D and GMP manufacturing facilities at Amsterdam Science Park.

Summary

VectorY is a Life Sciences company based in Amsterdam, Netherlands, founded in 2020. It has raised $175.6M in total across 2 rounds, most recently a $138.0M Series A round in Nov 2023. Investors include Forbion Growth Opportunities Fund, EQT AB and Forbion Capital Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ANov 2023
$138.0M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
PHC

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Minato, Japan5001–10000Healthcare, Life Sciences
Private EquityTotal funding$1.9BMar 2021

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

VectorY on Indexed.vc
<a href="https://indexed.vc/companies/vectory"><img src="https://indexed.vc/api/badge/company/vectory" alt="VectorY on Indexed.vc" width="260" height="76" /></a>